Squamous Cell Carcinoma of the Head and Neck
📧 Sign up to get email alerts when something new happens for Squamous Cell Carcinoma of the Head and Neck.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-07-03Clinical Trial Update: ASTX727 and Nivolumab in Squamous Cell Carcinoma of the Head and Neck [Phase 1]
A Phase 1 trial evaluating ASTX727 in combination with nivolumab for recurrent or metastatic squamous cell carcinoma of the head and neck ha…
-
CLINICAL_TRIALS withdrawal · 2019-12-20Clinical Trial Update: Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310) [Phase 3]
Phase 3 trial CheckMate 9NA/ECHO-310 evaluating nivolumab plus epacadostat with chemotherapy versus EXTREME in squamous cell carcinoma of th…
-
CLINICAL_TRIALS withdrawal · 2016-08-08Clinical Trial Update: A Phase II Study to Evaluate Low-Dose Fractionated Radiotherapy (LDFRT) [Phase 2]
A Phase II study evaluating low-dose fractionated radiotherapy for squamous cell carcinoma of the head and neck has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-03-10Clinical Trial Update: Effectiveness in Head and Neck Cancer Detection Using Positron Emission Tomography (PET) Insert Device
A clinical trial evaluating the effectiveness of a PET insert device for detecting head and neck cancer was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-08-19Clinical Trial Update: Concordance of Two Endoscopic Procedures for Diagnosis of Carcinoma of the Upper Aerodigestive Tract [NA]
A clinical trial assessing concordance of two endoscopic procedures for diagnosing carcinoma of the upper aerodigestive tract has been withd…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2014-06-17Clinical Trial Update: EMD 1201081 + 5-FU + Cisplatin + Cetuximab in Subjects With Recurrent / Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 1]
Phase 1 trial of EMD 1201081 plus 5-FU, cisplatin, and cetuximab in recurrent/metastatic squamous cell carcinoma of the head and neck has be…
-
CLINICAL_TRIALS withdrawal · 2012-01-19Clinical Trial Update: A Study of Conventional 3D Radiation vs. Intensity-Modulated Radiation in Squamous Cell Cancer of the Head and Neck [Phase 2, Phase 3]
A Phase 2/3 trial comparing conventional 3D radiation to intensity-modulated radiation therapy for squamous cell carcinoma of the head and n…